Pregnancy Surveillance Program of Women and Infants Exposed to TEGSEDI During Pregnancy
Latest Information Update: 17 Apr 2024
At a glance
- Drugs Inotersen (Primary)
- Indications Amyloid polyneuropathy; Amyloidosis
- Focus Adverse reactions
- Sponsors Akcea Therapeutics
- 08 Jul 2020 Planned initiation date (estimated date for recruitment of the first subject) changed from 17 Feb 2020 to 31 Dec 2020.
- 21 Feb 2020 New trial record